A Study to Assess Two Forms of The Study Medicine (Ritlecitinib) in Healthy Adult Participants

NCT05852340 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Adult
Pharmacokinetics

Interventions

DRUG: Ritlecitinib

Sponsor

Pfizer